Identification of Heptapeptides Interacting with IFN-α-Sensitive CML cells
Document Type
Article
Publication Date
12-1-2011
Abstract
BACKGROUND: Interferon-alpha (IFN-α) is the traditional therapeutic agent for chronic myeloid leukemia (CML). The molecular mechanism of IFN-α efficacy in the treatment of CML is not fully clear.
OBJECTIVES: To identify the peptides and/or proteins that bind to the proteins specifically expressed on the surface of IFN-α-sensitive CML cells by using a phage display library.
DESIGN/METHODS: IFN-α-sensitive KT-1/A3 cells were used as the target, and IFN-α-resistant subline KT-1/A3R was used as absorber for phage display biopanning. The positive phage clones were identified by enzyme-linked immunosorbent assay and flow cytometry. The peptides were deduced from their DNA sequences.
RESULTS: Multiple clones showed high binding efficiency to KT-1/A3 cells compared with that of the other leukemia cells. One of the peptides, KLWVIPQ, has a partial amino acid sequence homology with the C-terminal domain of E3 ubiquitin-protein ligase.
CONCLUSIONS: This study presents the identification of specific heptapeptides that bind to IFN-α-sensitive KT-1/A3 cells. The cancer-selective ligands provide novel strategies for early and differential diagnoses, as well as potential targeted drug delivery.
Publication Title
Expert Opinion on Investigational Drugs
Volume
20
Issue
12
First Page
1583
Last Page
1589
PubMed ID
22092230
Recommended Citation
Liu, Jia; Chen, Hanchun; Rao, Zhou-zhou; Khan, Md. Asaduzzaman; Wan, Xin-Xing; Xu, Ai-hua; Zhang, Nuo; and Zhang, Dianzheng, "Identification of Heptapeptides Interacting with IFN-α-Sensitive CML cells" (2011). PCOM Scholarly Works. 21.
https://digitalcommons.pcom.edu/scholarly_papers/21
Comments
This article was published in Expert Opinion on Investigational Drugs, Volume 20, Issue 12, December 2011, pages 1583-1589.
The published version is available at http://dx.doi.org/10.1517/13543784.2011.632407
Copyright © 2011 Informa Plc.